News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Micron has never before had this kind of market power, and it hasn’t taken long to throw around its newfound muscle.
The company says its new strategy is working in the stores it runs itself. But the numbers from its franchise partners tell a very different story - even if a sudden wave of internet mania just completely upended the stock chart.
Seeing how your retirement savings compare can be useful—but the real question is whether your balance fits your age, income, and goals.
Buffett has a clear opinion when it comes to IPOs.
US stock futures wavered as Wall Street digested a downbeat week for tech stocks.
<body><p>STORY: U.S. stocks ended mixed on Thursday, with the Dow ticking up more than a tenth of a percent, while the S&P 500 closed flat and the Nasdaq dropped nearly half a percent.</p><p>Technology shares reversed early gains to move lower, as investors worried about hyperscaler spending on AI and who foots the bill.</p><p>:: Micron</p><p>Those fears outweighed upbeat signals on AI demand from Micron, which gained nearly 16%, while shares of Sandisk soared 22%.</p><p>Brian Mulberry, chief market strategist at Zacks Investment Management, notes that it's memory chip makers that are now leading the charge. </p><p>"What's different about Micron, SanDisk, Western Digital, those types of names that are doing so well is that they're memory chips. And you have to have memory, specifically DRAM or H-band memory, if you're going to have enough computing power to do all the computations. That is nothing if you don't have memory to transfer it from one place to another. So one of the reasons that these stocks have done so well and the growth at Micron is so solid is because a recent redesign in the server technology means we go from eight memory chips per server to 96. That's 12 times growth in demand for this one simple component."</p><p>The surging prices of memory and storage chips prompted Apple on Thursday to hike prices for its iPads and MacBooks. That weighed on the stock, sending it down more than 6%. Shares of Nvidia, Microsoft and Alphabet also dropped.</p><p>:: Archive</p><p>Among other movers, shares of Bio-Techne jumped after Merck agreed to acquire the biotech firm for $73 per share in cash, representing a total enterprise value of about $11.3 billion.</p><p>:: Archive</p><p>Meanwhile, U.S. Department of Commerce data on Thursday showed the annual inflation rate through May rose above 4% for the first time in three years, but oil prices this week fell to below pre-war levels.</p></body>
Microsoft’s Azure growth remains a key support for the stock, with investors weighing whether AI demand can offset the rising cost of building cloud capacity.
In the closing of the recent trading day, Superior Group (SGC) stood at $13.16, denoting a -1.57% move from the preceding trading day.
American Tower (AMT) closed at $168.72 in the latest trading session, marking a -3.29% move from the prior day.
In the most recent trading session, Astrazeneca (AZN) closed at $185.68, indicating a +1.45% shift from the previous trading day.
The latest trading day saw Phillips 66 (PSX) settling at $171.76, representing a +1.85% change from its previous close.
In the latest trading session, Sunrun (RUN) closed at $13.6, marking a -5.69% move from the previous day.
The latest trading day saw Wix.com (WIX) settling at $41.72, representing a -2.07% change from its previous close.
In the latest trading session, Vital Farms (VITL) closed at $10.68, marking a -3.87% move from the previous day.
In the most recent trading session, Silicon Motion (SIMO) closed at $325.26, indicating a +1.12% shift from the previous trading day.
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.46, denoting a -2.83% move from the preceding trading day.
The latest trading day saw United Parcel Service (UPS) settling at $109.31, representing a +2.99% change from its previous close.
On June 25, 2026, investors tracked deal progress as Bio-Techne shares responded to the proposed buyout terms.